Shanghai RAAS Blood Products Co., Ltd.
002252
Clasificación en acciones
#3653
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Precio por acción
$0.70283234
Capitalización bursátil
$4.63B
Cambio (1 día)
-0.61%
Cambio (1 año)
-25.18%
País
CN
Comercio Shanghai RAAS Blood Products Co., Ltd. (002252)
Categoría
Healthcare
Ganancias de Shanghai RAAS Blood Products Co., Ltd. (002252)
Ganancias en Jun 2026 TTM: $217.03M
Secondo gli ultimi rapporti finanziari di Shanghai RAAS Blood Products Co., Ltd., gli utili attuali della società sono $217.03M. Nel 2023, la società ha registrato un utile di $311.37M, una disminución en comparación con agli utili del 2022, che erano di $329.61M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Shanghai RAAS Blood Products Co., Ltd. desde 2005 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| 2026 (TTM) | $217.03M | -39.54% |
| 2024 | $358.96M | 15.28% |
| 2023 | $311.37M | -5.53% |
| 2022 | $329.61M | 36.12% |
| 2021 | $242.14M | 7.08% |
| 2020 | $226.13M | 114.78% |
| 2019 | $105.29M | -141.25% |
| 2018 | $-255.27M | -265.29% |
| 2017 | $154.43M | -45.28% |
| 2016 | $282.21M | 4.77% |
| 2015 | $269.37M | 177.16% |
| 2014 | $97.19M | 248.88% |
| 2013 | $27.86M | -34.34% |
| 2012 | $42.43M | 13.57% |
| 2011 | $37.36M | 11.62% |
| 2010 | $33.47M | 43.19% |
| 2009 | $23.37M | 28.12% |
| 2008 | $18.24M | 35.94% |
| 2007 | $13.42M | 74.83% |
| 2006 | $7.68M | 1.12% |
| 2005 | $7.59M | 0.00% |
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| $5.27B | 2,330.53% |
US
|
|
| $-3.09B | -1,522.40% |
US
|
|
| $-4.02B | -1,950.55% |
AU
|
|
| - | - |
CH
|
|
| $1.95B | 798.81% |
NL
|
